UPLIZNA - Model IgG1 K - Humanized, Affinity-Optimized, Afucosylated Kappa

A humanized, affinity-optimized, afucosylated IgG1 kappa (IgG1κ) monoclonal antibody (mAb) that binds to the B cell-specific surface antigen CD19.

Most popular related searches

IgG4-Related Disease: Phase 3 trial evaluating UPLIZNA for the prevention of flare in patients with IgG4-related disease.

Myasthenia Gravis (MINT): Phase 3 trial evaluating UPLIZNA for improving outcomes in patients with myasthenia gravis.

Products Details